baber/WOPTO huggingface dataset:
Patent NZ-547212-A (NZ)
Title: Process for the production of a frozen food product using an emulsifier to prevent recrystallisation
Inventor: BARFOD NIELS MICHAEL
IPC: A23L29/10
Filed: 2004-12-17
Abstract: Disclosed is a process for the production of a frozen food product, comprising the steps of: i) contacting a food intermediate with an emulsifier system; and ii) subjecting the food intermediate to freezing conditions whilst agitating the food intermediate, wherein the emulsifier system consists essentially of compounds of formula I, wherein R1 is a hydrocarbon group and: a) unsaturated lactylated mono-diglycerides, or b) saturated mono-diglycerides, or c) saturated mono-diglycerides and unsaturated lactylated mono-diglycerides.
Patent NZ-548301-A (NZ)
Title: Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
Inventor: MAUS JOACHIM
IPC: A61K9/00
Filed: 2005-01-24
Abstract: Disclosed is a combination of R, R-glycopyrrolate or a physiologically acceptable salt thereof with a phosphodiesterase (PDE) 4 inhibitor selected fro the group comprising rolipram and roflumilast or a physiologically acceptable salt thereof for the treatment of respiratory diseases, including bronchial asthma and chronic obstructive pulmonary disease (COPD).
Patent NZ-550120-A (NZ)
Title: Extracts of passion fruit and uses thereof
Inventor: FOO LAI YEAP
IPC: A61K36/185
Filed: 2005-04-04
Abstract: Disclosed herein is a method for preparing a passion fruit extract which is useful as a medicament for lowering blood pressure, lowering serum nitric oxide levels, and preventing liver damage in a mammal (human and non-human). Also disclosed is the passion fruit extract comprising of a compound of the structure as shown in the disclosure which is prepared by said method.
Patent NZ-550775-A (NZ)
Title: Spiro amido compounds and their use as pharmaceuticals
Inventor: ZHUO JINCONG
IPC: C07D471/10
Filed: 2005-05-04
Abstract: Disclosed is a compound of Formula Va or Vb, or a pharmaceutically acceptable salt thereof, wherein B is a fused 5 or 6-membered aryl or heteroaryl group, R1 and R2 together with the C atom to which they are attached form a 3 to 7-membered optionally substituted cycloalkyl or hetercycloalkyl group, q is 0 or 1, and wherein the rest of the substituents are as described in the specification. Also disclosed is the use of the compound of modulating activity of 11betaHSD1 or MR, and for treating diseases such as obesity, diabetes, glucose intolerance, insulin resistance, hyperglycemia, hypertension, hyperlipidemia, cognitive impairment, dementia, glaucoma, hypertension, cardiovascular disorders, osteoporosis, inflammation, a renal or inflammatory disease, heart failure, atherosclerosis, arteriosclerosis, coronary artery disease, thrombosis, angina, peripheral vascular disease, vascular wall damage, stroke, dyslipidemia, hyperlipoproteinaemia, diabetic dyslipidemia, mixed dyslipidemia, hypercholesterolemia, hypertriglyceridemia, type 1 diabetes, type 2 diabetes, obesity, metabolic syndrome, insulin resistance or general aldosterone-related target organ damage.
Patent NZ-553073-A (NZ)
Title: Food container sealing apparatus
Inventor: DEWEY KEVIN J
IPC: B65B51/10
Filed: 2005-08-18
Abstract: Disclosed is an apparatus for sealing food containers using a sealing film. The apparatus includes a base, a container holder for holding a food container, a heater platen positioned within the base, a pressure applicator which is positioned on a surface of the heater platen, and wherein the pressure applicator applies pressure to the heater platen causing the heater platen to move into engagement with the sealing film to seal the sealing film to portions of the food container. The container holder includes a curved section configured to hold a roll of the sealing film such that a portion of the sealing film may be unrolled and pulled over the food container.
Patent NZ-562801-A (NZ)
Title: Polypeptides having antimicrobial activity and polynucleotides encoding same
Inventor: VIND JESPER
IPC: A23K20/195
Filed: 2006-06-02
Abstract: Disclosed is a polypeptide having antimicrobial activity, which comprises an amino acid sequence which has at least 80% identity with amino acids 1 to 40 of SEQ ID NO: 2 wherein the polypeptide comprises an amino acid sequence selected from the group consisting of SEQ 1D NO: 3 to 117, 226 to 251, and 252 to 262; and which has less than 100% identity with amino acids 1 to 40 of SEQ ID NO:1.
Patent NZ-567669-A (NZ)
Title: Compact fluorescent lamp
Inventor: LUCZENBACHER JANOS ISTVAN
IPC: H01J5/48
Filed: 2005-10-26
Abstract: A compact fluorescent lamp having a base, light-radiating members, and electronic and electric elements, is disclosed. The compact fluorescent lamp comprises a hollow column, a cap, and one or more light-radiating members. The hollow column, the outer surface of which is coated with heat-and light reflecting material, is attached to the base, and the cap closes the hollow column. One or more of the light-radiating members are secured to the cap and/or the hollow column closed with the cap. The light-radiating members start from the hollow column and are connected to an operating circuit formed by the electronic and electric elements and/or to at least one signal detecting detector, and pass through openings of the hollow column and/or the cap. The compact fluorescent lamp further comprises a guide ring to support the light-radiating members extending until or beyond a meeting boundary edge of the base and the hollow column. The hollow column, the base, the cap and the guide ring are encompassed with the light-radiating members and the light-radiating members extend from the cap towards the base and back, in at least a direction parallel with a longitudinal axis of the compact fluorescent lamp and the light-radiating members have curved sections.
Patent NZ-570178-A (NZ)
Title: Monitoring binder mix loading of fiber glass mats using visible and near infrared spectroscopy
Inventor: MBACHU REGINALD A
IPC: G01B15/00
Filed: 2007-02-13
Abstract: A process and apparatus for measuring the amount of binder mixed with glass fiber is disclosed. The process is used for monitoring production of construction insulation product such as roofing and wall insulation. The process utilises visible (VIS) and near infrared (NIR) spectroscopy in an on-line production processing following binder mix loading of glass fibres and prior to curing treatment of the mix. Such spectroscopic analysis can be carried out on a static or moving substrate. The blend is then conveyed to and through curing treatment to form an insulation product. The blend is exposed to VIS-NIR radiant energy, and a radiant energy sensor collects resulting data as to absorption following penetration of the VIS-NIR radiant energy. The spectroscopic instrumentation is calibrated to facilitate accuracy using samples of the mix measured using VIS and NIR absorption.
Patent NZ-570452-A (NZ)
Title: Feed for fish comprising extracts of Sage (Salvia officinalis) and/or Oregano (Origanum vulgare)
Inventor: KOPPE WOLFGANG
IPC: A23L17/00
Filed: 2007-01-16
Abstract: A method of promoting growth of fish and/or improving lipid and/or protein digestibility in fish is disclosed. The fish are feed with a feed comprising carvacrol and/or salvia extract, provided that where the fish feed comprises carvacrol and not salvia extract the lipid content of the fish feed is at least 15 wt%. A fish feed and a method of manufacture is also disclosed. Preferred species of salvia are Dalmatian sage (Salvia officinalis and Spanish sage (Salvia lavandulifolia). Carvacrol can be obtained from oregano (Origanum vulgare) and other plants.
Patent NZ-570833-A (NZ)
Title: Apparatus and method for reducing fluid drag on a submerged surface
Inventor: STUBBLEFIELD DONALD P
IPC: B63B1/34
Filed: 2006-01-27
Abstract: A method for reducing frictional drag on a hull and an apparatus that entrains a secondary fluid into a primary fluid flow while the primary fluid flows along a surface of an object is disclosed. The apparatus comprises an inlet, a flow diverting member, a second opening, and a free surface. A first portion of the primary fluid flows through the inlet, where the first portion of the primary fluid enters the inlet through a first opening and exits the inlet through at least one nozzle. At least a portion of the flow diverting member is located downstream from the first opening of the inlet and a second portion of the primary fluid flows over the flow diverting member. The second opening enables the secondary fluid to flow into a first region where the second opening is located at or downstream from the flow diverting member and the first region is between the surface of the object and the second portion of the primary fluid. The free surface consists of an area in which the second portion of the primary fluid abuts the first region. At least one nozzle directs the first portion of the primary fluid through the free surface.
Patent NZ-573823-A (NZ)
Title: Methods for the preparation of biologically active compounds in nanoparticulate form
Inventor: MEISER FELIX
IPC: A61P19/10
Filed: 2007-06-29
Abstract: Disclosed is a method for producing a composition comprising nanoparticles of a biologically active compound, comprising the step of: dry milling a solid biologically active compound and a millable grinding compound in a mill comprising a plurality of milling bodies, for a time period sufficient to produce a solid dispersion comprising nanoparticles of the biologically active compound dispersed in an at least partially milled grinding compound. Also disclosed is a composition made by the milling method and the use of the composition to manufacture a medicament. The milling bodies comprise material selected from the group consisting of: ceramics, glasses, polymers, Ferro magnets and metals. The average size less than a size selected from the group consisting of: 500 nanometers, 400nm, 300nm, 200nm, 100nm, 75nm and 10nm.
Patent NZ-573935-A (NZ)
Title: Merthod purification process in which column device is used with application of temperature difference in column
Inventor: WOUTERS HUIBRECHT ADRIAAN
IPC: B01D9/00
Filed: 2007-07-05
Abstract: Device and method for the purification and separation of a metal from a metal mother liquid that has a specific density and comprises one or more foreign element(s) is disclosed. The device comprises a column (10) defining separation chamber (11) having an inlet (18) for feeding starting material to be purified comprising metal crystals (26) and metal mother liquid. There is an outlet (20) in the device for discharging by-product material comprising at least one foreign element. The device is also provided with means for applying a temperature difference at the column (10), and means for adjusting the specific density of the metal crystals (26).
Patent NZ-581024-A (NZ)
Title: Evaluating a driver of a vehicle by measuring the driver's reaction to a stimulus and sensing how the driver controls the vehicle
Inventor: CAMBOURN JASON
IPC: A61B5/00
Filed: 2009-11-09
Abstract: 581024 Disclosed is a system for evaluating a driver of a vehicle. The system includes a means (104) for providing a stimulus to the driver, and means for determining a measure of the driver's reaction to the stimulus. Also included is an interface means (101) that controls the system, and at least one sensor (103) in the vehicle which provides data relating to the driver's control of the vehicle to the interface device (101). The interface means (101) utilises a processing means for interpreting the sensor data to provide a performance evaluation of the driver.
Patent NZ-583154-A (NZ)
Title: Beam forming system and method
Inventor: STYTSENKO EUGENE
IPC: G01S7/28
Filed: 2007-08-08
Abstract: A beam forming system (10) for acoustic or electromagnetic beams comprises one or more beam forming elements (2) that are arranged to provide a non-planar doubly ruled radiation surface. The surface is defined by two families of rulings and the length of the rulings within each family are configured to provide a radiation surface with substantially straight boundary edges. The beam forming elements can be acoustic transducer elements comprising an active acoustic material that is operatively driven by front and back electrodes provided on opposing surfaces of the active acoustic material.
Patent NZ-589159-A (NZ)
Title: Connecting structure for a container lid utilising locking flanges which connect to corresponding projections
Inventor: NAKAMURA KOHEI
IPC: F16B21/04
Filed: 2009-05-29
Abstract: Disclosed is a connecting structure that enables a first member to be connected to a second member by rotating the members relative to each other. The connecting structure (1A) connects a first member (2A) and a second member (3A). The first member comprises a connecting upright portion (21) and a plurality of locking flanges (22) provided to extend outwards along the circumferential direction of the outer face of the connecting upright portion. The second member comprises a connecting side-wall portion (32) that overlies the connecting upright portion and a plurality of locking projections (33) provided to extend inwards from the inner face of the connecting side-wall portion. The bottom faces of the locking flanges distend downwards in a convex curved shape and, when the second member is overlaid on the first member and rotated, the upper faces of the locking projections are guided with sliding contact along the convex curved bottom faces (23) of the locking flanges and stopped at the lowermost position of the convex curved bottom faces.
Patent NZ-591847-A (NZ)
Title: 3h-imidazo[4,5-c]pyridine-6-carboxamides as anti -inflammatory agents
Inventor: PFAU ROLAND
IPC: A61K31/4188
Filed: 2009-09-25
Abstract: 591847 Disclosed 2-(phenylamino)-3H-imidazo[4,5-c]pyridine-6-carboxylic acid amides as represented by the general formula (I), wherein each Q2, Q3, Q3a and Q4 are each selected from C and N, the carbon atom being substituted by a substituent as defined herein; A represents aryl, heteroaryl, heterocycloalkyl, cycloalkyl, alkyl, alkenyl or alkynyl, all of which are optionally substituted by one or more substituents selected from R9; and wherein the remaining substituents are as defined herein. Representative compounds include 2-(2,6-dichloro-phenylamino)-3H-imidazo[4,5-c]pyridine-6-carboxylic acid (4,4-dimethyl-cyclohexyl)-amide, 2-(2,6-dichloro-phenylamino)-3H-imidazo[4,5,c]pyridine-6-carboxylic acid cyclohexylamide, N-(4-Bromophenyl)-2-(2-chloro-6-fluoro-phenylamino)-3-methyl-3Himidazo[4,5-c]pyridine-6-carboxamide, 2-(3,5-dichloropyridin-4-ylamino)-N-(4,4-dimethylcyclohexyl)-3-methyl-3H-imidazo[4,5-c]pyridine-6-carboxamide, N-(4-cyclopropylpyridin-2-yl)-2-(2,6-dichlorophenylamino)-1Himidazo[4,5-c]pyridine-6-carboxamide. Further disclosed is a medicament which comprises a compound as defined above for the treatment of asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, inflammatory bowel disease, irritable bowel syndrome, pain, inflammatory pain, fever, migraine, headache, low back pain, fibromyalgia, a myofascial disorder, a viral infection, a bacterial infection, a fungal infection, dysmenorrhea, a burn, a surgical or dental procedure, a malignancy, hyperprostaglandin E syndrome, classic Bartter syndrome, atherosclerosis, gout, arthritis, osteoarthritis, juvenile arthritis, rheumatoid arthritis, rheumatic fever, ankylosing spondylitis, Hodgkin's disease, systemic lupus erythematosus, vasculitis, pancreatitis, nephritis, bursitis, conjunctivitis, iritis, scleritis, uveitis, wound healing, dermatitis, eczema, psoriasis, stroke, diabetes mellitus, a neurodegenerative disorder, an autoimmune disease, an allergic disorder, rhinitis, an ulcer, coronary heart disease, sarcoidosis, any other disease with an inflammatory component, osteoporosis, osteoarthritis, Paget's disease, a periodontal disease or a cancer.
Patent NZ-597619-A (NZ)
Title: Herbicidal benzoxazinones
Inventor: WITSCHEL MATTHIAS
IPC: A01N43/84
Filed: 2010-06-11
Abstract: 597619 Disclosed herein are benzoxazinone compounds of formula I, wherein the variables are defined herein; methods of preparation thereof, comprising a starting material of formula V, and intermediates of formula IV.d, III and IV.e; and use thereof as herbicides and desiccants/defoliants. Embodiments of the compound of formula I include the following: 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione.
Patent NZ-603342-A (NZ)
Title: Vibration isolation system for a respiratory treatment device
Inventor: SEARS DAVID BRENT
IPC: A61M16/00
Filed: 2007-10-24
Abstract: Disclosed is a Positive Airway Pressure (PAP) device (460) for generating a supply of pressurised gas to be provided to a patient for treatment. The PAP device (460) is comprised of a housing (462) having an inlet (467) and an outlet (not shown), a core (461) including a motor (410) and at least one impeller (468), and a vibration isolation system (455). The vibration isolation system (455) is arranged to support the core (461) within the housing (462) in a flexible, vibration-isolated manner.
Patent NZ-606802-A (NZ)
Title: Real-time robust method for determining the trajectory of one or more cetaceans by means of passive acoustics, using a laptop computer
Inventor: GLOTIN HERVE GILLES PIERRE
IPC: G01S5/22
Filed: 2008-09-03
Abstract: Disclosed is a method for the passive tracking of a plurality of objects, such as whales and other marine animals, emitting audible signals. In the case of whales, the signals may be in the form of a series of clicks. The method includes acquiring, during successive processing time windows, raw analogue signals using a plurality of sensors, such as hydrophones located in a marine environment. The raw analogue data are then converted into digital data by sampling at a sampling frequency. The method also includes filtering the digital data to eliminate spurious noise and eliminating echoes in the filtered signal. The echoes are eliminated by determining an envelope of the filtered signal, integrating the envelope over time windows, and comparing a result of the integrated envelope with a predetermined threshold. If the result is below the predetermined threshold, a signal corresponding to the result is determined to be one of the predetermined sounds and is stored in a memory. If the result is above the predetermined threshold, a signal corresponding to the result is determined to be an echo and is eliminated. The method further includes obtaining, for each pair of sensors and each processing window, potential values (TDOA) of differences in arrival time of the stored signals reaching two distinct sensors. For each pair of sensors, the coherence of the TDOAs is verified and a number (nbTDOA) of filtered TDOAs coherent with each other is determined. From the filtered and coherent TDOAs, the successive instantaneous positions of the sources of the predetermined sounds are determined by nonlinear regression and the paths of the plural objects in their environment determined in real time.
Patent NZ-615872-A (NZ)
Title: Method of washing adherent cell using trehalose-containing cell-washing solution
Inventor: KOBAYASHI EIJI
IPC: C12Q1/24
Filed: 2013-09-24
Abstract: Discloses a method of washing an adherent cell, comprising washing the adherent cell using a cell-washing solution , before detaching the adherent cell from a culture vessel by proteolytic enzyme treatment, wherein the cell-washing solution comprises a physiological aqueous solution added with trehalose or its derivative. Further discloses a cell-washing solution or trehalose when used to wash cells.
Patent NZ-700682-A (NZ)
Title: Production method for frozen noodles and composition for preventing freezer burn
Inventor: WATANABE TAKENORI
IPC: A23L29/269
Filed: 2013-04-05
Abstract: Provided is a frozen noodle that exhibits a low occurrence of freezer burn. The production method for this frozen noodle includes: a step in which a composition that contains at least water, oil/fat, and a polysaccharide thickener and that has a viscosity of 30-2000 mPa·s at 60 °C is affixed to cooked noodles; and a step in which the noodles to which the composition has been affixed are frozen.
Patent NZ-701290-A (NZ)
Title: Pyrrolobenzodiazepines
Inventor: HOWARD PHILIP WILSON
IPC: C07D487/04
Filed: 2013-04-30
Abstract: The present invention relates to pyrrolobenzodiazepines (PBDs) and in particular to PBD monomers with a 4-(1-methyl-1H-pyrrol-3-yl)phenyl based amino acid residue containing substituent and methods of synthesising PBD monomers. The inventors have found that cytoxiticy and DNA binding of prior art PBD conjugates can be improved by the incorporation of a single 4-(1-methyl-1H-pyrrol-3-yl)phenyl based amino acid residue in combination with a single heteroaryl based amino acid residue in a PBD conjugate. This results in highly effective compounds for the treatment of proliferative diseases. The present invention therefore provides a PBD compound of formula (I) or a salt or solvate thereof, wherein: the dotted double bond indicates the presence of a single or double bond between C2 and C3; R2 is selected from -H, -OH, =O, =CH2, -CN, -R, OR, halo, dihalo, =CHR, =CHRR’, -O-SO2-R, CO2R and COR; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR’, nitro, Me3Sn and halo; where R and R’ are independently selected from optionally substituted C1-7 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R10 and R11 either together form a double bond, or are selected from H and QRQ respectively, where Q is selected from O, S and NH and RQ is H or C1-7 alkyl or H and SOxM, where x is 2 or 3, and M is a monovalent pharmaceutically acceptable cation; A is either (A1) or (A2) where X and Y are selected from: CH and NMe; COH and NMe; CH and S; N and NMe; N and S; B is either a single bond or (B1) where X and Y are as defined above; and R1 is C1-4 alkyl.
Patent NZ-704579-A (NZ)
Title: Nasal stimulation devices and methods
Inventor: ACKERMANN DOUGLAS
IPC: A61N1/36
Filed: 2014-04-18
Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.
Patent NZ-711823-A (NZ)
Title: Ceftolozane antibiotic compositions
Inventor: TERRACIANO JOSEPH
IPC: C07D499/86
Filed: 2014-03-14
Abstract: This disclosure provides pharmaceutical compositions comprising ceftolozane, pharmaceutical compositions comprising ceftolozane and tazobactam, methods of preparing those compositions, and related methods and uses of these compositions. Specifically, ceftolozane is chemically unstable in certain lyophilized compositions, leading to the formation of degradation products. The methods of the present invention result in compositions having stabilized ceftolozane, thereby providing ceftolozane at a desired potency and with reduced impurities (degradation products). Stabilized compositions comprising ceftolozane and tazobactam can be prepared by lyophilizing ceftolozane in the absence of tazobactam and then blending the lyophilized ceftolozane with a solid tazobactam composition.